Buffered Anesthetic Solution in the Treatment of Mandibular Primary Molars

September 27, 2023 updated by: Damascus University

Evaluation of the Effect of Buffered Anesthetic Solution (Lidocaine 2%) in the Effectiveness of Inferior Alveolar Nerve Block Injection During the Treatment of Mandibular Primary Molars

In a prospective, randomized clinical trial, triple-blind, split-mouth study, 40 children aged between 7 to 10 with bilateral mandibular primary molars were diagnosed with pulpitis. The test agent was 2% lidocaine with 1:80.000 epinephrine buffered with sodium bicarbonate 8.4% at a ratio of 1/10, as opposed to the control agent, which was non- buffered 2% lidocaine with 1:80,000 epinephrine. The pain will be assessed during inferior alveolar nerve block injection (IANB) and the effectiveness of anesthesia using the subjective Wong-Baker visual analog scale, the objective sound, eye, and motor (SEM) scale, and the physiological pain scale (pulse rate) using a pulse oximeter. The investigator has confirmed the onset of anesthesia after lip tongue-numbing by probing the gingiva until there is no pain. Endo-ice has been used to assess the onset of pulp anesthesia.

Study Overview

Detailed Description

In a prospective, randomized clinical trial and triple-blind, split mouth study, 40 children aged between 7 to 10 with bilateral mandibular primary molars were diagnosed with pulpitis. Random numbers between 1 to 40 were assigned to patients, with some receiving buffered lidocaine at their initial appointment while others received unbuffered lidocaine. The solutions have been switched up for the second session, which has been set for one week later. The test agent was 2% lidocaine with 1:80.000 epinephrine buffered with sodium bicarbonate 8.4% at a ratio of 1/10, as opposed to the control agent, non-buffering 2% lidocaine with 1:80,000 epinephrine. Buffered lidocaine has been freshly prepared by mixing sodium bicarbonate (8.4%) with the anaesthetic solution (lidocaine 2% with epinephrine 1/80.000) in a 1:10 ratio by volume. Two percent benzocaine gel is applied at the injection site for one minute before inferior alveolar nerve block injection (IANB). The investigator has assessed pain during IANB injection using the subjective Wong-Baker visual analogue scale, the objective sound, eye, and motor (SEM) scale, and the physiological pain scale (pulse rate) using a pulse oximeter. After administering the IANB injection, the investigator has confirmed the onset of anaesthesia after lip and tongue numbing by probing the gingiva every 30 seconds until there is no pain. Endo-ice has been used to assess the onset of pulp anaesthesia every 30 seconds. The effectiveness of anaesthesia has been assessed during the preparation of the pulp chamber using subjective, objective, and physiological pain scales. Finally, the numerical data will be statistically analysed, and any statistically significant values will be investigated.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Al-Mazzeh Saint
      • Damascus, Al-Mazzeh Saint, Syrian Arab Republic, Damascus P.O.Box 3062
        • College of dentistry.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 10 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children who are healthy and free of any underlying conditions that might make local anesthesia impossible to administer.
  • Children that are not allergic to (lidocaine, adrenaline, or sodium bicarbonate).
  • Children aged 6-10 years old
  • Cooperative children on Frankel scale (positive or absolute positive).
  • children needing bilateral (right and left) endodontic treatment for the mandibular primary molars.
  • A positive outcome on the cold test for the target tooth.

Exclusion Criteria:

  • Uncooperative children on Frankel's scale (passive or absolute positive).
  • The presence of a fistula.
  • The presence of an abscess associated with the target tooth.
  • The presence of a periapical lesion radially.
  • Negative response to the cold test.
  • Children suffering from systemic conditions.
  • Children who are allergic to (lidocaine, adrenaline, sodium bicarbonate).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Buffered lidocaine
Inferior alveolar nerve block with buffered anesthetic solution (2% lidocaine with 1/80000 adrenaline mixed with sodium bicarbonate 8.4%)
Buffered Lidocaine 2% with epinephrine 1.80000 mixed with 1.8% sodium bicarbonate in IANB injection in the treatment of bilateral primary mandibular molars
Other Names:
  • Buffered lidocaine
Other: Lidocaine 2%

Control group:

Inferior alveolar nerve block with anesthetic solution (Lidocaine 2% with adrenaline 1.80000).

Lidocaine 2% with epinephrine 1.80000 in IANB injection in the treatment of bilateral primary mandibular molars

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probing the gingiva
Time Frame: directly after asking the child about lip, tongue numbing every 30 seconds until there is no pain.
The onset of anaesthesia at soft tissue will be assessed by probing the gingiva After IANB injection.
directly after asking the child about lip, tongue numbing every 30 seconds until there is no pain.
Endo - ice test
Time Frame: Every 30 seconds after confirmed soft tissues anaesthesia until the absence of pain.
The investigator will use endo-ice to assess the onset time of pulp anaesthesia.
Every 30 seconds after confirmed soft tissues anaesthesia until the absence of pain.
Pulse rate
Time Frame: A minute before anaesthesia.
Pulse rate is a physiological pain scale which will be taken through a finger pulse oximeter.
A minute before anaesthesia.
Pulse rate
Time Frame: 20 seconds after the first quarter of the local anaesthesia.
Pulse rate is a physiological pain scale, will be taken through a finger pulse oximeter.
20 seconds after the first quarter of the local anaesthesia.
Wong baker faces scale.
Time Frame: One minute after IANB injection
Wong Baker faces scale is a subjective pain which contains a series of six faces ranging from a happy face at 0 to indicate "no hurt" to a crying face at 10 to indicate "hurts worst"
One minute after IANB injection
Sound, eye, motor scale (SEM)
Time Frame: Within five seconds from the start of the local anesthetic injection to completion
Sound, eye, motor scale is an objective pain scale for the assessment of child's behaviour by recording video during anaesthesia
Within five seconds from the start of the local anesthetic injection to completion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulse rate
Time Frame: 20 seconds after opening the pulp chamber
Pulse rate is a physiological pain scale which will be taken through a finger pulse oximeter.
20 seconds after opening the pulp chamber
sound, eye, motor scale (SEM)
Time Frame: Within five seconds from the start of the local anaesthetic injection to completion
Sound, eye, motor scale is an objective pain scale for the assessment of child's behaviour by recording video during endo access preparation
Within five seconds from the start of the local anaesthetic injection to completion
Wong baker faces scale
Time Frame: one minute after preparing pulp chamber
Wong Baker faces scale is a subjective pain which contains a series of six faces ranging from a happy face at 0 to indicate "no hurt" to a crying face at 10 to indicate "hurts worst"
one minute after preparing pulp chamber

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hanadi Almattit, Phd,lecturer, Co- supervisal
  • Study Director: Chaza Kouchaji, Professor, Supervisal

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2022

Primary Completion (Actual)

March 1, 2023

Study Completion (Actual)

April 3, 2023

Study Registration Dates

First Submitted

February 7, 2023

First Submitted That Met QC Criteria

March 20, 2023

First Posted (Actual)

March 31, 2023

Study Record Updates

Last Update Posted (Actual)

September 29, 2023

Last Update Submitted That Met QC Criteria

September 27, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Local Anesthesia

Clinical Trials on Buffered lidocaine in inferior alveolar nerve block injection

3
Subscribe